Saggere Muralikrishna Shasthry
Overview
Explore the profile of Saggere Muralikrishna Shasthry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
409
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Varshney M, Kaur A, Sarin S, Shasthry S, Arora V
J Clin Exp Hepatol
. 2024 Dec;
15(2):102447.
PMID: 39640196
Background And Aims: Naltrexone is a promising drug to treat alcohol use disorder with limited evidence of safety in liver diseases. An observational study was performed to study the safety,...
2.
Shasthry S, Sarin S
Clin Liver Dis
. 2024 Oct;
28(4):621-631.
PMID: 39362711
Alcohol-associated liver disease (AALD) is a global health problem with increasing incidence with associated high morbidity and mortality. Patients with AALD have varied clinical presentation encompassing a spectrum ranging from...
3.
Mishra A, Shasthry S, Vijayaraghavan R, Kumar G, Sarin S
Am J Gastroenterol
. 2024 Aug;
PMID: 39162744
Introduction: Severe alcohol-associated hepatitis (SAH) carries high 1-month mortality. Corticosteroids provide a modest 28-day but not 90-day survival benefit, due to development of infections and organ failures. Granulocyte colony-stimulating factor...
4.
Varadarajan A, Rastogi A, Maiwall R, Bihari C, Thomas S, Shasthry S
Indian J Pathol Microbiol
. 2024 Jun;
67(4):846-851.
PMID: 38847214
Background: Serum immunoglobulin G (IgG) level is elevated in autoimmune liver diseases (AILDs), especially autoimmune hepatitis (AIH). However, its utility is limited in current practice as different criteria propose different...
5.
Varadarajan A, Rastogi A, Maiwall R, Bihari C, Thomas S, Sood V, et al.
Indian J Pathol Microbiol
. 2024 Feb;
67(1):107-114.
PMID: 38358198
Aims: Autoimmune liver diseases (AILD) represent a spectrum of related yet distinct immune-mediated disorders. The literature on the prevalence of these AILDs in Indian population is scarce. This study aims...
6.
Mukund A, Yadav T, Singh S, Shasthry S, Maiwall R, Patidar Y, et al.
Indian J Radiol Imaging
. 2023 Dec;
34(1):25-31.
PMID: 38106869
Direct intrahepatic portosystemic shunt (DIPS) stent placement is an effective treatment for patients with Budd-Chiari syndrome (BCS); however, thrombotic occlusion of DIPS stent remains a cause of concern. The purpose...
7.
Patil N, Sahai P, Rastogi A, Sharma N, Shasthry S, Mukund A, et al.
Indian J Pathol Microbiol
. 2023 Dec;
66(4):744-750.
PMID: 38084526
Background: Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is an uncommon form of primary liver carcinoma. It is heterogenous in terms of morphology, immunohistochemistry, radiology, and clinical features; making it a challenging entity for...
8.
Kar P, Venishetty S, Laroia S, Jindal A, Maiwall R, Sood A, et al.
Indian J Gastroenterol
. 2023 Jul;
42(4):505-516.
PMID: 37422602
Background And Aims: Twenty per cent albumin (1.5 g/kg at diagnosis and 1 g/kg on day three, infused over six-hour duration) is recommended particularly in high-risk spontaneous bacterial peritonitis (SBP)....
9.
Pande A, Sharma S, Khillan V, Rastogi A, Arora V, Shasthry S, et al.
Hepatol Int
. 2022 Dec;
17(1):249-261.
PMID: 36469298
Background: Severe alcoholic hepatitis (SAH) has high 90-day mortality. Prednisolone therapy has shown modest survival benefits over placebo at 28 but not 90 days. Fecal microbial transplantation (FMT) has shown...
10.
Jagdish R, Kamaal A, Shasthry S, Benjamin J, Maiwall R, Jindal A, et al.
Hepatol Int
. 2021 Nov;
17(2):434-451.
PMID: 34775577
Background And Aims: Patients with cirrhosis have high prevalence of erectile dysfunction (ED). The aim of this study was to study the efficacy and safety of tadalafil for ED in...